DBD Financial Facts
Research, development and engineering expense: 17.6MInterest expense: -24.3M
See Full Income Statement
Postretirement and other benefits: 19.4M
Total liabilities and equity: 4.04B
See Full Balance Sheet
Diebold, Incorporated (DBD) Earnings
|
Expand Research on DBD
| Next EPS Date | 5/2/24 | EPS Growth Rate | +191.8% |
|---|---|---|---|
| Average EPS % Beat Rate | -384.9% | Revenue Growth Rate | +4.2% |
| Average % Move 1-Wk after EPS | +10.8% | Normal Earnings Time | Before Open |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
5/2/24  |
Q124 | N/A | $0.78 | N/A | N/A | $894.26M | N/A | N/A | N/A | ||
| 2/14/24 | Q423 | $3.02 | $1.34 | +$1.68 | $1.04B | $1.03B | N/A |  | | Details | |
| 11/9/23 | Q323 | -$2.86 | $0.81 | -$3.67 | $943.3M | $956.6M | = | | | Details | |
| 8/30/23 | Q223 | N/A | N/A | N/A | N/A | N/A | = | N/A | N/A | ||
| 8/2/23 | Q223 | N/A | $0.31 | N/A | N/A | $929.61M | = | N/A | N/A | ||
| 5/3/23 | Q123 | -$0.85 | $0.07 | -$0.92 | $858.1M | $896.04M | = | | | Details | |
| 2/9/23 | Q422 | $0.79 | $0.39 | +$0.40 | $968.8M | $1.03B | = | | | Details | |
| 11/8/22 | Q322 | -$0.12 | $0.24 | -$0.36 | $810.4M | $843.5M |  |
| | Details |
